Citigroup sale of its Brazilian unit should face tougher scrutiny from the nation’s antitrust office because the local banking industry is already highly concentrated, one of the agency’s regulators said.
Any banking mergers should immediately be deemed “complex,” Cristiane Alkmin Junqueira Schmidt, a member of the agency, said Wednesday. “I am really uncomfortable approving any transaction in the banking industry, especially one made by the nation’s four biggest banks.”
Citigroup said in February it would sell its retail-banking and credit-card operations in Brazil. Chief Executive Officer Mike Corbat has been scaling back Citigroup’s retail footprint to simplify the company, cut costs and boost returns.
State-controlled Banco do Brasil SA and Caixa Economica Federal along with Itau Unibanco Holding SA and Banco Bradesco SA are the nation’s four biggest banks by assets, according to the central bank. Cade, the antitrust agency, on Wednesday unanimously approved Bradesco’s acquisition of the local unit of HSBC Holdings Plc, adding a restriction that the buyer refrain from additional purchases for 30 months. The agency had previously said that deal required more extensive review than normal, also because of concern about concentration in the market.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas